Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum
Saved in:
| Main Authors: | Nika Kotnik, MD, Gilles F.H. Diercks, MD, PhD, Hilde Jalving, MD, PhD, Geke A.P. Hospers, MD, PhD, Sjoukje F. Oosting, MD, PhD, Michel van Kruchten, MD, PhD, T. Jeroen N. Hiltermann, MD, PhD, Maria C. Bolling, MD, PhD, Jeroen Bremer, PhD, Barbara Horváth, MD, PhD, Joost M. Meijer, MD, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512625001456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bullous pemphigoid treated with baricitinib as steroid-sparing therapy for a patient with uncontrolled diabetes
by: Ji Won Heo, MD, et al.
Published: (2025-03-01) -
Atypical bullous systemic lupus erythematosus with features of linear IgA bullous dermatosis
by: Roy Jiang, MD, PhD, et al.
Published: (2025-04-01) -
Dupilumab as a novel steroid-sparing treatment for pemphigoid gestationis: A new case report and review of literature
by: Celine H. Phong, MD, et al.
Published: (2025-06-01) -
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01) -
Immune Checkpoint Inhibitors in Kidney Transplant Recipients: A French Multicenter Retrospective Cohort Study
by: Tristan Legris, MD, et al.
Published: (2025-09-01)